A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers

British Journal of Clinical Pharmacology

Volumn 46, Issue 3, 1998, Pages 245-249

  Bardsley, Hazel ^a   Gristwood, Robert ^a   Baker, Helen ^a   Watson, Norma ^b   Nimmo, Walter ^b  

^a Chiroscience Ltd   (United Kingdom)

^b Inveresk Clinical Research   (United Kingdom)

Author keywords

Cardiovascular function; Levobupivacaine; rac bupivacaine; S( ) enantiomer; Volunteers

Indexed keywords

BUPIVACAINE;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENANTIOMER; HEART INDEX; HEART OUTPUT; HEART RATE; HUMAN; HUMAN EXPERIMENT; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; ISOMER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ADULT; ANESTHETICS, LOCAL; BLOOD PRESSURE; BUPIVACAINE; CARDIOVASCULAR SYSTEM; CROSS-OVER STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; STEREOISOMERISM;

EID: 0031718230     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00775.x     Document Type: Article

References (20)

1. Covino BG. Clinical pharmacology of local anaesthetic agents. In Neural blockade in clinical anaesthesia and management of pain, 2nd ed, eds Cousins MJ, Bridenbaugh PO, Philadelphia: JB Lippincott Co., 1988; 111-144.
2. Brennum J, Nielsen PT, Horn A, et al. Quantitative sensory examination of epidural anaesthesia and analgesia in man; dose-response effect of bupivacaine. Pain 1994; 56: 315-326.
3. Crandell JT, Kotelco DM. Cardiotoxicity of local anaesthetics during late pregnancy. Anesth Analg 1985; 64: 204.
4. de Jong RH. Local anaesthetics. St Louis: Mosby - Year Book, 1994.
5. Strichartz GR, Berde CB. Local anaesthetics. In Anaesthesia, 4th ed, ed Miller RD, New York: Churchill Livingstone, 1994.
6. Santos AC, Pedersen H. Current controversies in obstetric anaesthesia. Anesth Analg 1994; 78: 753-760.
7. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563-569.
8. Åberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol 1972; 31: 273-286.
9. Lee-Son S, Wang GK, Concus A, et al. Stereoselective inhibition of neuronal sodium channels by local anaesthetics. Anesthesiol 1992; 77: 324-335.
10. Vanhoutte F, Vereecke J, Verbeke N, Carmeliet E. Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle. Br J Pharmacol 1991; 103: 1275-1281.
11. Denson DD, Behbehani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992; 17: 311-316.
12. Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993; 77: 477-482.
13. + channels is dependent on c-AMP. Anesthesiol 1995; 83: A304.
14. Graf BM, Vicenzi MN, Kwok WM, et al. Enantiomer-specific component of bupivacaine alters only AV-conduction in isolated hearts. Anesthesiol 1994; 81: A749.
15. Liu S, Paul GE, Carpenter RL, et al. Prolonged PR interval is a risk factor for bradycardia during spinal anaesthesia. Reg Anesth 1995; 20: 41-44.
16. Rutten AJ, Nancarrow C, Mather LE, et al. Hemodynamic and central nervous system effects of intravenous bolus doses of lignocaine, bupivacaine, and ropivacaine in sheep. Anesth Analg 1989; 69: 291-299.
17. McCaughey W. Adverse effects of local anaesthetics. Drug Safety 1992; 7: 178-189.
18. Bernhards CM, Artru AA. Hexamethonium and midazolam terminate dysrhythmias and hypertension caused by intracerebroventricular bupivacaine in rabbits. Anesthesiol 1991; 74: 89-96.
19. Butterworth JF, Brownlow RC, Leith JP, et al. Bupivacaine inhibits cyclic-3′,5′-adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity. Anesthesiol 1993; 79: 88-95.
20. Coyle DE, Porembka DT, Sehlhorst CS, Wan L, Behbehani MM. Echocardiographic evaluation of bupivacaine cardiotoxicity. Anesth Analg 1994; 79; 335-339.